It was reported that on (b)(6) 2017, the patient was implanted with an afx bifurcated device for an abdominal aneurysm.During the deployment of the contralateral limb, resistance was felt, the physician continued to pull the surpass wire and it was removed from the body.However, it was noted that the contralateral limb covered was still attached to the stent graft and the contralateral limb was not completely deployed.A snare catheter was inserted and the cover was removed from the main body to successfully deploy the main body.The surepass wire was removed and inspected, it was confirmed that the proximal bead was missing.The cuff was implanted without issue.There have been no patient sequelae reported.
|
At the completion of the clinical evaluation, based on the information received there were no substantial evidence to support the following reported events; resistance pulling the surepass wire, and detachment of the contralateral limb cover.This event included a patient involvement.A clinical assessment was required, but no medical information was provided.This assessment was based upon the reported event, cumulative knowledge informed by past assessments of similar complaints, and/or other non-medical, relative information such as, but not limited to: still photographs; videos; sizing/case planning sheet/summary.The most likely cause of the detachment of the component and the sure-pass wire issue could not be determined due to lack of relevant medical information.Unable to determine procedure-related, anatomy-related and user-related issues, off label, or cautionary product use conditions.Associated clinical harms for this event included: no known impact to the patient.The final patient disposition was unknown however there have been no additional negative patient sequelae reported.Devices remain implanted in the patient and were not returned, no evaluation completed.The review of manufacturing lot confirmed all devices met specifications prior to release.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.(b)(4).
|